Markus Blaess

5PUBLICATIONS
7CO-AUTHORS
Electrochemical energy storage and conversionCharacterisation of biological macromoleculesMetabolic medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 14, 2024
Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs.

Markus Blaess, René Csuk, Teresa Schätzl

|Mar 06, 2021
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.

Markus Blaess, Lars Kaiser, Oliver Sommerfeld

|Aug 28, 2020
Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways.

Lars Kaiser, Helga Weinschrott, Isabel Quint

|Jul 17, 2020
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.

Markus Blaess, Lars Kaiser, Martin Sauer

|Aug 25, 2019
Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy.

Markus Blaess, Hans-Peter Deigner

Pageof 1